ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

CoQ10's Potential Capabilities for Your Health

Testosterone replacement therapy associated with improved urinary, sexual function

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

The Many Potential Health Benefits of Curcumin

8 Chia Seed Recipes

Cinnamon Health Benefits Proven

 
Print Page
Email Article

Differential responses by psychosocial subgroups of fibromyalgia (FM) syndrome patients to an interdisciplinary treatment

  [ 65 votes ]   [ Discuss This Article ]
By Turk DC, Okifuji A, Sinclair JD, Starz TW • www.ProHealth.com • October 5, 1998


OBJECTIVES: To evaluate differential treatment responses among
3 empirically derived, psychosocial subgroups of patients with
fibromyalgia syndrome to a standard interdisciplinary
treatment program.

METHOD: Patients were classified into 1 of
3 psychosocial groups on the basis of their responses to the
Multidimensional Pain Inventory. Forty-eight patients
completed a 6 one-half-day outpatient treatment program
consisting of medical, physical, occupational, and
psychological therapies spaced over a period of 4 weeks (3
sessions the first week followed by 1 session per week for the
next 3 consecutive weeks).

RESULTS: Statistically significant
reductions were observed in pain, affective distress,
perceived disability, and perceived inteference of pain in the
patients characterized by poor coping and high level of pain
("dysfunctional" group). In contrast, individuals who were
characterized by interpersonal difficulties ("interpersonally
distressed" group) exhibited poor responses to the treatment.
"Adaptive copers," the third group, revealed significant
improvements in pain but due to low pretreatment levels of
affective distress and disability showed little improvement on
these outcomes.

CONCLUSIONS: The results provided support for
the hypothesis that customizing treatment based on patients'
psychosocial needs will lead to enhanced treatment efficacy.
They also emphasize the importance of using appropriate
outcome criteria, as low levels of problems at baseline are
not likely to show significant changes following any
treatment.




Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Ultra ATP+, Double Strength Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep? Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep?
Cocoa's Polyphenol Riches - All the Health Benefits without the Sugar, Calories or Guilt Cocoa's Polyphenol Riches - All the Health Benefits without the Sugar, Calories or Guilt
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map